How many insider trades does FilingIQ track for MDXH?

FilingIQ tracks 14 Form 4 insider transactions for MDXH (MDxHealth SA), covering filings from Feb 3, 2023 onwards. 13 of those were filed in the last 90 days.

Are MDXH insiders net buyers or net sellers?

Across the full Form 4 history for MDXH, 1 transactions (7%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MDXH insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MDXH in?

MDxHealth SA (MDXH) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $30.99M.

MDXH insider trading

NasdaqCM Healthcare

MDxHealth SA — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

7% / 0%

Market cap

$30.99M

About MDxHealth SA

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. It offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company has a collaboration the initiation of Genomic Prostate Score (GPS) testing. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Company website: mdxhealth.com

MDXH insider activity at a glance

FilingIQ has scored 14 insider transactions for MDXH since Feb 3, 2023. The most recent filing in our index is dated Jun 1, 2026.

Across the full history, 1 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MDXH insider trades is 48.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MDXH trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,234

UNITED THERAPEUTICS Corp

APLS 277

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 187

Guardant Health, Inc.

BMY 182

BRISTOL MYERS SQUIBB CO

HOLX 142

HOLOGIC INC

ADPT 140

Adaptive Biotechnologies Corp

KNSA 139

Kiniksa Pharmaceuticals International, plc

Frequently asked

How many insider trades does FilingIQ track for MDXH?: FilingIQ tracks 14 Form 4 insider transactions for MDXH (MDxHealth SA), covering filings from Feb 3, 2023 onwards. 13 of those were filed in the last 90 days.
Are MDXH insiders net buyers or net sellers?: Across the full Form 4 history for MDXH, 1 transactions (7%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MDXH insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MDXH in?: MDxHealth SA (MDXH) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $30.99M.

Methodology & sources

Every MDXH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.